Received Dec 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 7PK53 | — |
Administration of a pediatric dose to an adult patient; Underdose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of adult use of a child product in a 60-year-old female patient who received HAV (Havrix 720) (batch number 7PK53, expiry date 04-MAR-2026) for prophylaxis. On 13-DEC-2025, the patient received Havrix 720. On 13-DEC-2025, an unknown time after receiving Havrix 720, the patient experienced adult use of a child product (Verbatim: Administration of a pediatric dose to an adult patient) and underdose (Verbatim: Underdose). The outcome of the adult use of a child product and underdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 17-DEC-2025 The pharmacist asked whether the dose should be readministered as if the pediatric dose had not been given or what the appropriate recommendation would be.